Global Smoking Cessation Clinical Trial Pipeline Highlights 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Global Smoking Cessation Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.

Smoking Cessation Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives in tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Smoking Cessation pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Smoking Cessation pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Smoking Cessation pipeline products by the company.

Short-term Launch Highlights:

Find out which Smoking Cessation pipeline products will be launched in the US and Ex-US to 2024.

Summary:

  • Smoking Cessation phase 3 clinical trial pipeline products
  • Smoking Cessation phase 2 clinical trial pipeline products
  • Smoking Cessation phase 1 clinical trial pipeline products
  • Smoking Cessation preclinical research pipeline products
  • Smoking Cessation discovery stage pipeline products
  • Smoking Cessation pipeline products short-term launch highlights

Key Topics Covered:

1. Smoking Cessation Pipeline by Stages

2. Smoking Cessation Phase 3 Clinical Trial Insights

3. Smoking Cessation Phase 2 Clinical Trial Insights

4. Smoking Cessation Phase 1 Clinical Trial Insights

5. Smoking Cessation Preclinical Research Insights

6. Smoking Cessation Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/ur885v

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Over the Counter (OTC) Drugs, Clinical Trials, Addiction Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Over the Counter (OTC) Drugs, Clinical Trials, Addiction Disorders Drugs